Skip to main content
Adjuvants vétérinaires prêts à l'emploi

b博金冠平台注册: MONTANIDE? Range

博金冠平台是否已经被警方打击 www.ofvo6.com.cn Ready-to-use veterinary adjuvants

Selecting the right adjuvant is one of the keys to success of a veterinary vaccine in the field. Safety and efficacy balance must be taken into account, as well as the animal species and its sensitivity, the antigen (inactivated or live), its type (viral, bacterial, parasite) and its nature (crude extract, purified, recombinant, peptide, DNA), the desired immune response kinetics (short or long-term) and its profile (humoral or cellular), and the administration route (injection, mucosal, mass vaccination). Since the 70's, SEPPIC has been combining expertise and service to develop MONTANIDE? adjuvants adapted to the veterinary needs.

MONTANIDE? range

To meet vaccine developers' needs and to improve efficacy and stability of veterinary vaccines, SEPPIC has developed a wide range of ready-to-use adjuvants based on 3?technologies: emulsions, micro-emulsions and polymers.

These veterinary adjuvants are manufactured under International Pharmaceutical Excipient Council (IPEC) manufacturing guidelines in SEPPIC manufacturing sites of Castres (France) and Qing Pu (China).

MONTANIDE? safety and regulatory status

Based on toxicological tests and field experience, MONTANIDE? adjuvants are considered as safe for veterinary applications such as vaccines.

MONTANIDE? adjuvants and their components have been approved by the Committee for Veterinary Medical Products (CVMP) for use in immunological products. Their components are either included in the Allowed Substances table of the Annex to European Council Regulation (EU) No?37/2010 as substances needing no further Maximum Residue Limits (MRL) studies, or considered as not falling within the scope of Regulation (EC) No?470/2009 when used in a veterinary product.

The properties of the antigenic medium are crucial for both vaccine efficacy and safety. Each team developing a vaccine has to study the safety and efficacy profile of the formula under development according to local market acceptance criteria.

Services around MONTANIDE?

Expertise and know how
Bibliographic searches, vaccination protocols, efficacy screening on mice

Formulation studies
Selection among pharmaceutical technologies (emulsion, polymer, solid form, etc.)

Selection of samples
Adapted to the model of the customer for vaccine stability and performance

Scale-up assistance
From the laboratory to small and large scale industrial production

Customized formulation
For specific antigens, delivery systems, new concepts

Training & worshops
Vaccine formulation, laboratory and pilot processes, quality control of adjuvants and vaccines

Regulatory affairs support
For vaccine registration, customs, etc.

  • 外媒称中俄元首达成重要共识 两国合作达到历史最高水平 2019-02-23
  • 永济“审理轮训”有力提升执纪执法水平 2019-02-23
  • 哪个不在痛打落水狗呢 2019-02-22
  • 深化对经济工作主线的认识 从供需关系看供给侧结构性改革 2019-02-21
  • 联播快讯:尘暴席卷火星  “机遇”号休眠失联 2019-02-20
  • 端午节赛龙舟!这样的龙舟比赛你见过吗? 2019-02-19
  • 全球都在抛售美债,俄罗斯单月卖掉一半 2019-02-19
  • 10名藏医学子首次被授予临床医学硕士学位 2019-02-18
  • 大力弘扬革命传统传承红色基因 持续深化作风建设造福老区人民 2019-02-17
  • 发挥自身优势 奋力走在前列——习近平总书记在山东考察回访记 2019-02-17
  • 简直不要命!男子开车窗偷摸狮子遭狂吼吓破胆 2019-02-16
  • 一个理想的数列递减,看着就想笑,根本放不出什么屁来 2019-02-16
  • 【记者直击】花莲地震已确认有两名失踪人员被困同一地点 2019-02-15
  • 【家国网聚·网络旺年】把春节慰问效益做大,让旺年过得更旺 2019-02-15
  • 组图:高考迎来“00后” 北京6万余名考生走进考场 2019-02-14
  • 619| 143| 568| 496| 639| 617| 486| 951| 835| 815|